Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)
Link
https://www.nature.com/articles/s41366-023-01321-5.pdf
Reference60 articles.
1. Chong B, Kong G, Shankar K, Chew HSJ, Lin C, Goh R, et al. The global syndemic of metabolic diseases in the young adult population: a consortium of trends and projections from the Global Burden of Disease 2000–2019. Metabolism. 2023;141:155402. https://doi.org/10.1016/j.metabol.2023.155402.
2. Chew NWS, Ng CH, Tan DJH, Kong G, Lin C, Chin YH, et al. The global burden of metabolic disease: Data from 2000 to 2019. Cell Metab. 2023;35:414–28.e3. https://doi.org/10.1016/j.cmet.2023.02.003.
3. Organisation WH. Obesity and overweight fact sheet. World Health Organisation. Accessed 01/05/2022, 2022. https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight.
4. Kinlen D, Cody D, O’Shea D. Complications of obesity. QJM. 2018;111:437–43. https://doi.org/10.1093/qjmed/hcx152.
5. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American association of clinical endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22:1–203. https://doi.org/10.4158/EP161365.GL.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Is Tirzepatide the New Game Changer in Type 2 Diabetes?;Endocrines;2024-02-01
2. Tirzepatide as a novel effective and safe strategy for treating obesity: a systematic review and meta-analysis of randomized controlled trials;Frontiers in Public Health;2024-01-31
3. Revolutionizing diabetes care: unveiling tirzepatide’s potential in glycemic control and beyond;Expert Review of Clinical Pharmacology;2024-01-24
4. Non-canonical G protein signaling;Pharmacology & Therapeutics;2024-01
5. Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age;Nutrients;2023-12-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3